Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

RenovoRx, Inc. (RNXT) vs Verrica Pharmaceuticals Inc. (VRCA)

RenovoRx, Inc. and Verrica Pharmaceuticals Inc. are both Biotechnology companies. RenovoRx, Inc. and Verrica Pharmaceuticals Inc. are of similar size ($75.8M and $74.9M). Verrica Pharmaceuticals Inc. has the higher net margin (−102.8% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Verrica Pharmaceuticals Inc. leads on 10 and RenovoRx, Inc. on 5.

Valuation

Metric RNXT VRCA Biotechnology median
P/E n/m n/m 7.88
P/S 39.73 3.07 11.47
P/B 8.74 21.62 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 37.37 3.14 10.73
Earnings yield (18.67%) (38.22%) (28.84%)
Free cash flow yield (15.20%) (14.60%) (23.03%)

Profitability

Metric RNXT VRCA Biotechnology median
Gross margin 84.41% 85.89% 65.16%
Operating margin (685.22%) (93.59%) 0.00%
Net margin (621.71%) (102.84%) 0.00%
Free cash flow margin (604.10%) (44.02%) 0.00%
Return on equity (125.23%) 473.29% (57.72%)
Return on assets (97.83%) (83.02%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RNXT VRCA Biotechnology median
Revenue growth (TTM) — 106.21% 5.64%
EPS growth (last fiscal year) 20.00% 88.65% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RNXT VRCA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 5.74 1.45 4.73
Net debt to EBITDA 0.56 2.59 0.96

Dividend

Metric RNXT VRCA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric RNXT VRCA Biotechnology median
Market cap 75.82m 74.90m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack